Q2 results: Pfizer reports 52.11 percent decline in net profit at Rs 148.96 crore
Advertisement
New Delhi: Drug firm Pfizer Ltd has reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023.
The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer.
Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period.
Read also: USFDA nod for Pfizer Meningococcal vaccine Penbraya
Total expense was at Rs 410.76 crore, down 5.66 per cent.
Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.
Read also: Pfizer gains unconditional EU antitrust nod for proposed USD 43 billion Seagen acquisition
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.